Finally, we were not able to observe any statistically significant differences of BAFF peripheral blood level in MS patients positive or negative to the human homologous peptides MBP and IRF5 with or without Methylprednisolone therapy. The gene discussed is MBP; the disease is myeloid sarcoma.